Bulk order orladeyo for veteran care.
Ended Awarded Last action
- Contract number
- 36C26025F0296
- Awardee
-
Biocryst Pharmaceuticals Inc. UEI MGXADJ6SCLJ5
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $29,408
Award facts
- Contract value 100% obligated
- $29,407.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Earth City, MO 63045, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$352,893 | |
| Original award | $382,301 |
About this award
This is a $382,300.88 firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Biocryst Pharmaceuticals Inc., a biotechnology company that specializes in developing drugs for rare diseases. The contract is for the bulk order of ORLADEYO, a drug used to treat hereditary angioedema, to support veteran healthcare. The contract is not set aside and is part of Biocryst's Federal Supply Schedule (FSS) contract with the General Services Administration (GSA) for Pharmaceuticals and Drugs, which has a $1.25 million ceiling and an ultimate completion date of May 14, 2026. Biocryst also maintains a $10 million Blanket Purchase Agreement (BPA) with the VA's National Acquisition Center for expedited procurement of ORLADEYO and another drug, RAPIVAB, which is used to treat influenza. This contract award demonstrates Biocryst's role as a key pharmaceutical supplier to the VA, providing critical medications to support healthcare services for veterans.
Quick answers
Who was awarded contract 36C26025F0296?
36C26025F0296 was awarded to Biocryst Pharmaceuticals Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on September 9, 2025.
How much is contract 36C26025F0296 worth?
The government has obligated $29,408 on 36C26025F0296.
Is contract 36C26025F0296 an order under another contract?
Yes. 36C26025F0296 is a delivery order under 36F79721D0166, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26025F0296 competed?
The extent of competition for 36C26025F0296 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award